STERIS Product — Cost of Product and Service Sold increased by 7.0% to $418.20M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 12.5%, from $371.70M to $418.20M. Over 3 years (FY 2022 to FY 2025), Product — Cost of Product and Service Sold shows relatively stable performance with a 2.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests margin compression due to rising input costs or production inefficiencies, while a decrease relative to revenue suggests improved operational leverage or cost management.
This metric captures the direct costs associated with manufacturing, sourcing, and delivering the products and services...
Comparable to 'Cost of Goods Sold' (COGS) or 'Cost of Revenue' reported by peers in the medical device and industrial manufacturing sectors.
ste_segment_product_cost_of_product_and_service_sold| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $271.41M | $427.48M | $373.79M | $347.24M | $332.86M | $351.08M | $374.73M | $212.70M | $320.48M | $350.38M | $383.65M | $461.58M | $340.40M | $368.70M | $371.70M | $433.38M | $359.70M | $390.80M | $418.20M |
| QoQ Change | — | +57.5% | -12.6% | -7.1% | -4.1% | +5.5% | +6.7% | -43.2% | +50.7% | +9.3% | +9.5% | +20.3% | -26.3% | +8.3% | +0.8% | +16.6% | -17.0% | +8.6% | +7.0% |
| YoY Change | — | — | — | — | +22.6% | -17.9% | +0.3% | -38.7% | -3.7% | -0.2% | +2.4% | +117.0% | +6.2% | +5.2% | -3.1% | -6.1% | +5.7% | +6.0% | +12.5% |